Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
BlackRock 2037 Municipal Target Term Trust Common Shares of Beneficial Interest
BlackRock California Municipal Income Trust
BlackRock Credit Allocation Income Trust
BlackRock Floating Rate Income Trust
BlackRock Health Sciences Term Trust Common Shares of Beneficial Interest
BlackRock Income Trust Inc. (The)
BlackRock Innovation and Growth Term Trust Common Shares of Beneficial Interest
BlackRock Municipal 2030 Target Term Trust
BlackRock Taxable Municipal Bond Trust Common Shares of Beneficial Interest
Blackrock Core Bond Trust
Blackrock Corporate High Yield Fund, Inc. Common Stock
Blackrock Debt Strategies Fund, Inc. Common Stock
Blackrock Enhanced Equity Dividend Trust
Blackrock Enhanced Government Fund, Inc. Common Stock
Blackrock Floating Rate Income Strategies Fund Inc Common Stock
Blackrock Limited Duration Income Trust
Blackrock MuniYield Pennsylvania Quality Fund Common Stock
Concorde International Group Ltd - Class A Ordinary Shares
Global Compliance Applications Corp
Global Compliance Applications Corp
Jupiter Acquisition Corporation - Warrants
Ostin Technology Group Co., Ltd. - Class A Ordinary Shares
POMDOCTOR LIMITED - Class A Ordinary Shares
Vistagen Therapeutics, Inc. - Common Stock
Wheels Up Experience Inc. Class A Common Stock
zSpace, Inc. - Common stock
Edit Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
Articles published by ADMA Biologics, Inc.
< Previous
1
2
Next >
ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024
October 29, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Set to Join S&P SmallCap 600 Index
September 17, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference
September 10, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Partial Paydown of Revolving Credit Facility
August 14, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update
August 08, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024
August 01, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
May 02, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
March 11, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
March 05, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces CFO Transition
February 28, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
February 28, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
February 21, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics
February 21, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update
January 08, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management
December 18, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older
December 12, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD
November 16, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update
November 08, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023
November 01, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
August 09, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023
August 02, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
July 19, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update
May 10, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023
May 03, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Amendment to Credit Agreement
May 02, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 23, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023
March 16, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA
February 08, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance
January 17, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.